头颈部癌症中的血管周干细胞龛。
Perivascular stem cell niche in head and neck cancer.
机构信息
Department of Cariology, Restorative Sciences and Endodontics, University of Michigan, School of Dentistry, United States.
出版信息
Cancer Lett. 2013 Sep 10;338(1):41-6. doi: 10.1016/j.canlet.2012.07.025. Epub 2012 Jul 25.
Abstract
Cancers may contain a small sub-population of uniquely tumorigenic cells that exhibit self-renewal and multipotency, i.e. cancer stem cells (CSCs). These cells reside in invasive fronts in close proximity to blood vessels in many tumors, including head and neck squamous cell carcinomas (HNSCCs). Recent evidence suggests that CSC resist chemotherapy and "drive" local recurrence and metastatic spread. Notably, endothelial cell-initiated signaling is critical for the survival and self-renewal of CSC and may play a role in resistance to therapy. Therefore, patients with head and neck cancer might benefit from therapies that target the CSC directly or their supportive perivascular niche.
摘要
癌症可能包含一小部分具有独特肿瘤发生能力的细胞亚群，这些细胞表现出自我更新和多能性，即癌症干细胞（CSC）。这些细胞存在于许多肿瘤的侵袭前沿，靠近血管，包括头颈部鳞状细胞癌（HNSCC）。最近的证据表明，CSC 抵抗化疗，并“驱动”局部复发和转移扩散。值得注意的是，内皮细胞启动的信号对于 CSC 的存活和自我更新至关重要，并且可能在治疗抵抗中发挥作用。因此，头颈部癌症患者可能受益于直接针对 CSC 或其支持性血管周龛的治疗。
相似文献
1
Perivascular stem cell niche in head and neck cancer.头颈部癌症中的血管周干细胞龛。
Cancer Lett. 2013 Sep 10;338(1):41-6. doi: 10.1016/j.canlet.2012.07.025. Epub 2012 Jul 25.
2
Cancer stem cells hypothesis and stem cells in head and neck cancers.癌症干细胞假说与头颈部癌症中的干细胞
Cancer Treat Rev. 2012 Aug;38(5):515-39. doi: 10.1016/j.ctrv.2011.11.007. Epub 2011 Dec 23.
3
The biology of head and neck cancer stem cells.头颈部癌症干细胞的生物学特性。
Oral Oncol. 2012 Jan;48(1):1-9. doi: 10.1016/j.oraloncology.2011.10.004. Epub 2011 Nov 8.
4
Head and neck cancer stem cells.头颈部癌症干细胞。
J Dent Res. 2012 Apr;91(4):334-40. doi: 10.1177/0022034511423393. Epub 2011 Sep 20.
5
Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.内皮细胞起始的信号转导促进了癌症干细胞的存活和自我更新。
Cancer Res. 2010 Dec 1;70(23):9969-78. doi: 10.1158/0008-5472.CAN-10-1712. Epub 2010 Nov 23.
6
Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.头颈部鳞状细胞癌原发灶及淋巴结转移灶中假定干细胞标志物CD44/CD133的检测：一项初步的免疫组织化学及体外研究
Clin Otolaryngol. 2015 Aug;40(4):312-20. doi: 10.1111/coa.12368.
7
CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.CD133/Src 轴介导体瘤起始特性和头颈部癌症的上皮-间充质转化。
PLoS One. 2011;6(11):e28053. doi: 10.1371/journal.pone.0028053. Epub 2011 Nov 28.
8
Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.人类头颈部鳞状细胞癌中表面标志物 CD271 和 CD44 的癌症干细胞富集。
Carcinogenesis. 2020 Jun 17;41(4):458-466. doi: 10.1093/carcin/bgz182.
9
5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.5T4靶向治疗可消除癌症干细胞并预防头颈部鳞状细胞癌复发。
Clin Cancer Res. 2017 May 15;23(10):2516-2527. doi: 10.1158/1078-0432.CCR-16-1834. Epub 2016 Oct 25.
10
Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.对头颈部鳞状细胞癌中具有干细胞特性的癌细胞进行鉴定、扩增及特性分析。
Exp Cell Res. 2016 Oct 15;348(1):75-86. doi: 10.1016/j.yexcr.2016.09.003. Epub 2016 Sep 9.
引用本文的文献
1
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory.肠道药物工厂：靶向肿瘤干细胞的微生物组天然产物
Int J Mol Sci. 2023 Mar 5;24(5):4997. doi: 10.3390/ijms24054997.
2
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination.头颈部癌中的电穿孔：免疫疗法与纳米技术相结合的创新方法。
Cancers (Basel). 2022 Oct 31;14(21):5363. doi: 10.3390/cancers14215363.
3
Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma.探索癌症干细胞微环境的起源及其在胶质母细胞瘤抗血管生成治疗中的作用。
Front Oncol. 2022 Aug 25;12:947634. doi: 10.3389/fonc.2022.947634. eCollection 2022.
4
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.头颈癌的精准医学：基因组学与临床前研究方法
J Pers Med. 2022 May 24;12(6):854. doi: 10.3390/jpm12060854.
5
Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer.分泌活性成骨细胞特异性因子2在促进头颈癌进展和转移中的作用
Cancers (Basel). 2022 May 9;14(9):2337. doi: 10.3390/cancers14092337.
6
Advancement in Cancer Stem Cell Biology and Precision Medicine-Review Article Head and Neck Cancer Stem Cell Plasticity and the Tumor Microenvironment.癌症干细胞生物学与精准医学的进展——综述文章 头颈部癌症干细胞可塑性与肿瘤微环境
Front Cell Dev Biol. 2022 Jan 3;9:660210. doi: 10.3389/fcell.2021.660210. eCollection 2021.
7
Tumor-propagating side population cells are a dynamic subpopulation in undifferentiated pleomorphic sarcoma.肿瘤增殖性侧群细胞是未分化多形性肉瘤中具有活力的亚群。
JCI Insight. 2021 Nov 22;6(22):e148768. doi: 10.1172/jci.insight.148768.
8
Survival of salivary gland cancer stem cells requires mTOR signaling.唾液腺癌干细胞的存活需要 mTOR 信号。
Cell Death Dis. 2021 Jan 21;12(1):108. doi: 10.1038/s41419-021-03391-7.
9
HPV oral-tongue cancer stem cells: A potential target for relapse-free therapy.人乳头瘤病毒口腔舌癌干细胞：无复发生存治疗的潜在靶点。
Transl Oncol. 2021 Jan;14(1):100919. doi: 10.1016/j.tranon.2020.100919. Epub 2020 Oct 24.
10
SCF/C-Kit Signaling Induces Self-Renewal of Dental Pulp Stem Cells.SCF/C-Kit 信号诱导牙髓干细胞自我更新。
J Endod. 2020 Sep;46(9S):S56-S62. doi: 10.1016/j.joen.2020.06.035.
本文引用的文献
1
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.抗血管生成药物通过产生肿瘤缺氧增加乳腺癌干细胞。
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2784-9. doi: 10.1073/pnas.1018866109. Epub 2012 Jan 23.
2
Cancer statistics, 2012.癌症统计数据，2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
3
UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.UM-SCC-104：一种新型的人乳头瘤病毒 16 阳性的含有癌症干细胞的头颈部鳞状细胞癌细胞系。
Head Neck. 2012 Oct;34(10):1480-91. doi: 10.1002/hed.21962. Epub 2011 Dec 13.
4
ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.ERK1/2 调控 CD44 调节口腔癌侵袭性。
Cancer Res. 2012 Jan 1;72(1):365-74. doi: 10.1158/0008-5472.CAN-11-1831. Epub 2011 Nov 15.
5
Endothelial derived factors inhibit anoikis of head and neck cancer stem cells.内皮细胞衍生因子抑制头颈部肿瘤干细胞的失巢凋亡。
Oral Oncol. 2012 Jan;48(1):26-32. doi: 10.1016/j.oraloncology.2011.09.010. Epub 2011 Oct 19.
6
Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.人口腔癌细胞中癌症干细胞样侧群细胞的分离与鉴定。
Oral Oncol. 2011 Sep;47(9):855-60. doi: 10.1016/j.oraloncology.2011.06.501. Epub 2011 Jul 16.
7
CD44 as a stem cell marker in head and neck squamous cell carcinoma.CD44 作为头颈部鳞状细胞癌中的干细胞标志物。
Oncol Rep. 2011 Aug;26(2):321-6. doi: 10.3892/or.2011.1322. Epub 2011 May 26.
8
Evidence for label-retaining tumour-initiating cells in human glioblastoma.人胶质母细胞瘤中具有自我更新能力的肿瘤起始细胞的证据。
Brain. 2011 May;134(Pt 5):1331-43. doi: 10.1093/brain/awr081. Epub 2011 Apr 22.
9
Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells.CD44+头颈部鳞状细胞癌细胞对凋亡诱导刺激的抵抗。
Head Neck. 2012 Mar;34(3):336-43. doi: 10.1002/hed.21732. Epub 2011 Apr 5.
10
Hallmarks of cancer: the next generation.癌症的特征：下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
Zotero 插件